{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:41:27Z","timestamp":1769204487043,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T00:00:00Z","timestamp":1409788800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12865-014-0028-1","type":"journal-article","created":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T13:10:17Z","timestamp":1409749817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Memory B cell subsets and plasmablasts are lower in early than in long-standing Rheumatoid Arthritis"],"prefix":"10.1186","volume":"15","author":[{"given":"Anna Laura","family":"Fedele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Tolusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Gremese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Laura","family":"Bosello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Carbonella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Canestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Ferraccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,4]]},"reference":[{"issue":"5","key":"28_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/ard.62.5.427","volume":"62","author":"J Vencovsk\u00fd","year":"2003","unstructured":"Vencovsk\u00fd J, Mach\u00e1cek S, Sedov\u00e1 L, Kafkov\u00e1 J, Gatterov\u00e1 J, Pes\u00e1kov\u00e1 V, R\u016fzickov\u00e1 S: Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis. 2003, 62 (5): 427-430. 10.1136\/ard.62.5.427.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"28_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/rheumatology\/kel237","volume":"46","author":"KP Machold","year":"2007","unstructured":"Machold KP, Stamm TA, Nell VP, Pflugbeil S, Aletaha D, Steiner G, Uffmann M, Smolen JS: Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford). 2007, 46 (2): 342-349. 10.1093\/rheumatology\/kel237.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"28_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA: Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004, 50 (2): 380-386. 10.1002\/art.20018.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"28_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/ard.2005.041376","volume":"65","author":"E Berglin","year":"2006","unstructured":"Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantap\u00e4\u00e4-Dahlqvist S: Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis. 2006, 65 (4): 453-458. 10.1136\/ard.2005.041376.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"28_CR5","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1136\/ard.2010.148759","volume":"70","author":"K Chatzidionysiou","year":"2011","unstructured":"Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, Gabay C, van Riel PL, Nordstr\u00f6m DC, Gomez-Reino J, Pavelka K, Tomsic M, Kvien TK, van Vollenhoven RF: Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries. Ann Rheum Dis. 2011, 70 (9): 1575-1580. 10.1136\/ard.2010.148759.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"28_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/BOR.0b013e3283369cb8","volume":"22","author":"B Marston","year":"2010","unstructured":"Marston B, Palanichamy A, Anolik JH: B cells in the pathogenesis and treatment of rheumatoid arthritis. Curr Opin Rheumatol. 2010, 22 (3): 307-315. 10.1097\/BOR.0b013e3283369cb8.","journal-title":"Curr Opin Rheumatol"},{"key":"28_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1600-065X.2008.00627.x","volume":"223","author":"GJ Silverman","year":"2008","unstructured":"Silverman GJ, Boyle DL: Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B cell roadblock hypothesis. Immunol Rev. 2008, 223: 175-185. 10.1111\/j.1600-065X.2008.00627.x.","journal-title":"Immunol Rev"},{"issue":"4","key":"28_CR8","doi-asserted-by":"publisher","first-page":"R114","DOI":"10.1186\/ar2773","volume":"11","author":"JE Gottenberg","year":"2009","unstructured":"Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X: Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. Arthritis Res Ther. 2009, 11 (4): R114-10.1186\/ar2773.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"28_CR9","first-page":"1256","volume":"35","author":"S Bosello","year":"2008","unstructured":"Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, Morelli A, Ferraccioli G: Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol. 2008, 35 (7): 1256-1264.","journal-title":"J Rheumatol"},{"issue":"2\u20133","key":"28_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jaut.2007.07.002","volume":"29","author":"A Fekete","year":"2007","unstructured":"Fekete A, Soos L, Szekanecz Z, Szabo Z, Szodoray P, Barath S, Lakos G: Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses. J Autoimmun. 2007, 29 (2\u20133): 154-163. 10.1016\/j.jaut.2007.07.002.","journal-title":"J Autoimmun"},{"issue":"3","key":"28_CR11","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1186\/ar2718","volume":"11","author":"MM Souto-Carneiro","year":"2009","unstructured":"Souto-Carneiro MM, Mahadevan V, Takada K, Fritsch-Stork R, Nanki T, Brown M, Fleisher TA, Wilson M, Goldbach-Mansky R, Lipsky PE: Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor. Arthritis Res Ther. 2009, 11 (3): R84-10.1186\/ar2718.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"28_CR12","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1136\/annrheumdis-2012-201456","volume":"72","author":"E Gremese","year":"2013","unstructured":"Gremese E, Salaffi F, Bosello SL, Ciapetti A, Bobbio-Pallavicini F, Caporali R, Ferraccioli G: Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study. Ann Rheum Dis. 2013, 72 (6): 858-862. 10.1136\/annrheumdis-2012-201456.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"28_CR13","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/rheumatology\/keq029","volume":"49","author":"RA Moura","year":"2010","unstructured":"Moura RA, Weinmann P, Pereira PA, Caetano-Lopes J, Canh\u00e3o H, Sousa E, Mour\u00e3o AF, Rodrigues AM, Queiroz MV, Souto-Carneiro MM, Gra\u00e7a L, Fonseca JE: Alterations on peripheral blood B-cell subpopulations in very early arthritis patients. Rheumatology (Oxford). 2010, 49 (6): 1082-1092. 10.1093\/rheumatology\/keq029.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"28_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.clim.2008.11.011","volume":"131","author":"B Tolusso","year":"2009","unstructured":"Tolusso B, De Santis M, Bosello S, Gremese E, Gobessi S, Cuoghi I, Totaro MC, Bigotti G, Rumi C, Efremov DG, Ferraccioli G: Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype. Clin Immunol. 2009, 131 (1): 98-108. 10.1016\/j.clim.2008.11.011.","journal-title":"Clin Immunol"},{"issue":"11","key":"28_CR15","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.4049\/jimmunol.1302209","volume":"192","author":"C Klasen","year":"2014","unstructured":"Klasen C, Ohl K, Sternkopf M, Shachar I, Schmitz C, Heussen N: MIF Promotes B Cell Chemotaxis through the Receptors CXCR4 and CD74 and ZAP-70 Signaling. J Immunol. 2014, 192 (11): 5273-5284. 10.4049\/jimmunol.1302209.","journal-title":"J Immunol"},{"issue":"3","key":"28_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31 (3): 315-324. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"28_CR17","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, M\u00e9nard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, et al: 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010, 62 (9): 2569-2581. 10.1002\/art.27584.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"28_CR18","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1136\/ard.2010.142729","volume":"70","author":"S Bosello","year":"2011","unstructured":"Bosello S, Fedele AL, Peluso G, Gremese E, Tolusso B, Ferraccioli G: Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression. Ann Rheum Dis. 2011, 70 (7): 1292-1295. 10.1136\/ard.2010.142729.","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 39","key":"28_CR19","first-page":"S93","volume":"23","author":"J Fransen","year":"2005","unstructured":"Fransen J, van Riel PL: The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol. 2005, 23 (5 Suppl 39): S93-S99.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"28_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM van Gestel","year":"1996","unstructured":"van Gestel AM, Prevoo ML, van\u2019t Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL: Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria. Arthritis Rheum. 1996, 39 (1): 34-40. 10.1002\/art.1780390105.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"28_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/rheumatology\/35.11.1101","volume":"35","author":"ML Prevoo","year":"1996","unstructured":"Prevoo ML, van Gestel AM, van T Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL: Remission in a prospective study of patients with rheumatoid arthritis: American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol. 1996, 35 (11): 1101-1105. 10.1093\/rheumatology\/35.11.1101.","journal-title":"Br J Rheumatol"},{"issue":"5 Suppl 39","key":"28_CR22","first-page":"S100","volume":"23","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Smolen J: The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005, 23 (5 Suppl 39): S100-S108.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"28_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.smim.2007.12.006","volume":"20","author":"I Sanz","year":"2008","unstructured":"Sanz I, Wei C, Lee FE, Anolik J: Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol. 2008, 20 (1): 67-82. 10.1016\/j.smim.2007.12.006.","journal-title":"Semin Immunol"},{"issue":"18","key":"28_CR24","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1056\/NEJMoa023143","volume":"348","author":"M Crespo","year":"2003","unstructured":"Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marc\u00e9 S, L\u00f3pez-Guillermo A, Campo E, Montserrat E: ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med. 2003, 348 (18): 1764-1775. 10.1056\/NEJMoa023143.","journal-title":"N Engl J Med"},{"issue":"9\u201310","key":"28_CR25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2119\/molmed.2011.00034","volume":"17","author":"A Michelutti","year":"2011","unstructured":"Michelutti A, Gremese E, Morassi F, Petricca L, Arena V, Tolusso B, Alivernini S, Peluso G, Bosello SL, Ferraccioli G: B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. Mol Med. 2011, 17 (9\u201310): 901-909.","journal-title":"Mol Med"},{"issue":"1","key":"28_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1084\/jem.20080611","volume":"206","author":"JA Duty","year":"2009","unstructured":"Duty JA, Szodoray P, Zheng NY, Koelsch KA, Zhang Q, Swiatkowski M, Mathias M, Garman L, Helms C, Nakken B, Smith K, Farris AD, Wilson PC: Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med. 2009, 206 (1): 139-151. 10.1084\/jem.20080611.","journal-title":"J Exp Med"},{"issue":"2","key":"28_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1600-6143.2011.03833.x","volume":"12","author":"EG Kamburova","year":"2012","unstructured":"Kamburova EG, Koenen HJ, Boon L, Hilbrands LB, Joosten I: In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells. Am J Transplant. 2012, 12 (2): 341-350. 10.1111\/j.1600-6143.2011.03833.x.","journal-title":"Am J Transplant"},{"issue":"10","key":"28_CR28","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","volume":"178","author":"C Wei","year":"2007","unstructured":"Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, Lee EH, Milner EC, Sanz I: A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol. 2007, 178 (10): 6624-6633. 10.4049\/jimmunol.178.10.6624.","journal-title":"J Immunol"},{"issue":"2","key":"28_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/rheumatology\/keq338","volume":"50","author":"RA Moura","year":"2011","unstructured":"Moura RA, Casc\u00e3o R, Perp\u00e9tuo I, Canh\u00e3o H, Vieira-Sousa E, Mour\u00e3o AF, Rodrigues AM, Polido-Pereira J, Queiroz MV, Ros\u00e1rio HS, Souto-Carneiro MM, Graca L, Fonseca JE: Cytokine pattern in very early rheumatoid arthritis favours B cell activation and survival. Rheumatology (Oxford). 2011, 50 (2): 278-282. 10.1093\/rheumatology\/keq338.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"28_CR30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","volume":"62","author":"H Kokkonen","year":"2010","unstructured":"Kokkonen H, S\u00f6derstr\u00f6m I, Rockl\u00f6v J, Hallmans G, Lejon K, Rantap\u00e4\u00e4 Dahlqvist S: Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum. 2010, 62 (2): 383-391.","journal-title":"Arthritis Rheum"},{"issue":"11\u201312","key":"28_CR31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2119\/molmed.2010.00067","volume":"16","author":"G Ferraccioli","year":"2010","unstructured":"Ferraccioli G, Bracci-Laudiero L, Alivernini S, Gremese E, Tolusso B, De Benedetti F: Interleukin-1\u03b2 and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis. Mol Med. 2010, 16 (11\u201312): 552-557.","journal-title":"Mol Med"},{"issue":"12","key":"28_CR32","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.3899\/jrheum.120153","volume":"39","author":"E Gremese","year":"2012","unstructured":"Gremese E, Tolusso B, Fedele AL, Canestri S, Alivernini S, Ferraccioli G: Baseline ZAP-70+ B cell subset influences response to B-cell depletion therapy (BCDT) and early repopulation in Rheumatoid Arthritis. J Rheumatol. 2012, 39 (12): 2276-2285. 10.3899\/jrheum.120153.","journal-title":"J Rheumatol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12865-014-0028-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-014-0028-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-014-0028-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-014-0028-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T06:11:20Z","timestamp":1717308680000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-014-0028-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1186\/s12865-014-0028-1","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,4]]},"assertion":[{"value":"5 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"28"}}